Literature DB >> 7671268

Surgical treatment of intraventricular tumors associated with tuberous sclerosis.

M Roszkowski1, K Drabik, S Barszcz, S Jozwiak.   

Abstract

Six children with intraventricular tumors associated with tuberous sclerosis (TS) were treated at the Children's Health Center, Department of Pediatric Neurosurgery, in the period 1987-1992. The age of the patients ranged from 7 to 15 years. TS was diagnosed according to Gomez diagnostic criteria. Computer tomography (CT) and magnetic resonance imaging showed intraventricular tumors associated with ventricular enlargement and multiple subependymal nodules commonly observed in cases of TS. All tumors were removed totally through frontal transcortical approach, with uneventful postoperative recovery. One patient, with two parallel tumors in the two frontal horns, underwent one-stage surgery with successful total removal. Histopathological examination in all cases showed subependymal giant cell astrocytoma (SGCA). The growth pattern of SGCA associated with TS, documented by sequential CT scans over several years, is described. The diagnosis and surgical treatment of the tumor are discussed, and periodic CT scanning, at least every 2 years, is recommended for patients with TS.

Entities:  

Mesh:

Year:  1995        PMID: 7671268     DOI: 10.1007/bf00301665

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.475


  15 in total

1.  A new surgical approach to subcortical lesions: balloon inflation and cortical gluing. Technical note.

Authors:  J F Hirsch; C Sainte-Rose
Journal:  J Neurosurg       Date:  1991-06       Impact factor: 5.115

2.  Tuberous sclerosis.

Authors:  K Stefansson
Journal:  Mayo Clin Proc       Date:  1991-08       Impact factor: 7.616

Review 3.  Varieties of expression of tuberous sclerosis.

Authors:  M R Gomez
Journal:  Neurofibromatosis       Date:  1988

4.  Sequential CT study of subependymal giant-cell astrocytoma associated with tuberous sclerosis. Case report.

Authors:  K Morimoto; H Mogami
Journal:  J Neurosurg       Date:  1986-12       Impact factor: 5.115

5.  Subependymal giant-cell astrocytoma associated with tuberous sclerosis. Do subependymal nodules grow?

Authors:  S Fujiwara; T Takaki; T Hikita; S Nishio
Journal:  Childs Nerv Syst       Date:  1989-02       Impact factor: 1.475

6.  Connatal brain tumors in patients with tuberous sclerosis.

Authors:  M J Painter; D Pang; M Ahdab-Barmada; I Bergman
Journal:  Neurosurgery       Date:  1984-05       Impact factor: 4.654

7.  Causes of death in patients with tuberous sclerosis.

Authors:  C W Shepherd; M R Gomez; J T Lie; C S Crowson
Journal:  Mayo Clin Proc       Date:  1991-08       Impact factor: 7.616

8.  Diagnostic value of clinical features and supplementary investigations in tuberous sclerosis in children.

Authors:  S Józwiak
Journal:  Acta Paediatr Hung       Date:  1992

9.  Neuroimaging in tuberous sclerosis: a clinicoradiological evaluation in pediatric patients.

Authors:  F Menor; L Martí-Bonmatí; F Mulas; C Poyatos; H Cortina
Journal:  Pediatr Radiol       Date:  1992
View more
  10 in total

1.  Neurosurgical treatment of subependymal giant cell astrocytomas in tuberous sclerosis complex: a series of 44 surgical procedures in 31 patients.

Authors:  Flavio Giordano; Carla Moscheo; Matteo Lenge; Roberto Biagiotti; Francesco Mari; Iacopo Sardi; Anna Maria Buccoliero; Lorenzo Mongardi; Eleonora Aronica; Renzo Guerrini; Lorenzo Genitori
Journal:  Childs Nerv Syst       Date:  2019-12-18       Impact factor: 1.475

Review 2.  Giant cells: contradiction to two-hit model of tuber formation?

Authors:  Jaroslaw Jozwiak; Sergiusz Jozwiak
Journal:  Cell Mol Neurobiol       Date:  2005-08       Impact factor: 5.046

Review 3.  Management of subependymal giant cell tumors in tuberous sclerosis complex: the neurosurgeon's perspective.

Authors:  Moncef Berhouma
Journal:  World J Pediatr       Date:  2010-05-21       Impact factor: 2.764

4.  Subependymal giant cell astrocytoma in children with tuberous sclerosis.

Authors:  Vicente Cuccia; Graciela Zuccaro; Fidel Sosa; Jorge Monges; Fabiana Lubienieky; Ana Lia Taratuto
Journal:  Childs Nerv Syst       Date:  2003-03-18       Impact factor: 1.475

5.  Surgery for subependymal giant cell astrocytomas in children with tuberous sclerosis complex.

Authors:  Martine Fohlen; Sarah Ferrand-Sorbets; Olivier Delalande; Georg Dorfmüller
Journal:  Childs Nerv Syst       Date:  2018-05-15       Impact factor: 1.475

6.  Subependymal giant cell astrocytoma: a report of five cases.

Authors:  Raj Kumar; Vinita Singh
Journal:  Neurosurg Rev       Date:  2004-08-12       Impact factor: 3.042

7.  Identification of TSC1 or TSC2 mutation limited to the tumor in three cases of solitary subependymal giant cell astrocytoma using next-generation sequencing technology.

Authors:  Martine Fohlen; Ines Harzallah; Marc Polivka; Fabienne Giuliano; Linda Pons; Nathalie Streichenberger; Georg Dorfmüller; Renaud Touraine
Journal:  Childs Nerv Syst       Date:  2020-02-26       Impact factor: 1.475

Review 8.  Giant cells: contradiction to two-hit model of tuber formation?

Authors:  Jaroslaw Jozwiak; Sergiusz Jozwiak
Journal:  Cell Mol Neurobiol       Date:  2006-08-09       Impact factor: 4.231

Review 9.  Subependymal giant cell astrocytoma (SEGA): a case report and review of the literature.

Authors:  Layla Tahiri Elousrouti; Meryem Lamchahab; Nawal Bougtoub; Hinde Elfatemi; Laila Chbani; Taoufik Harmouch; Mustapha Maaroufi; Afaf Amarti Riffi
Journal:  J Med Case Rep       Date:  2016-02-09

10.  EFFECTS: an expanded access program of everolimus for patients with subependymal giant cell astrocytoma associated with tuberous sclerosis complex.

Authors:  Andras Fogarasi; Liesbeth De Waele; Gabriella Bartalini; Sergiusz Jozwiak; Nicola Laforgia; Helene Verhelst; Borivoj Petrak; Jean-Michel Pedespan; Olaf Witt; Ramon Castellana; Stefania Crippa; Gabriella Gislimberti; Zsuzsanna Gyorsok
Journal:  BMC Neurol       Date:  2016-08-08       Impact factor: 2.474

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.